DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Safety and Tolerability of Pirtobrutinib in B-Cell Malignancies: BRUIN Phase 1/2 Study Mar 07, 2023
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma A Promising Phase 1/2 Study of Pirtobrutinib in R/R CLL/SLL Patients Pre-Treated with cBTKi Mar 07, 2023
CLL (Chronic Lymphocytic Leukemia),Leukemia Safety of Subcutaneous Mosunetuzumab in Refractory B-Cell Lymphomas: Trial Results Mar 07, 2023
CLL (Chronic Lymphocytic Leukemia),Leukemia Mosunetuzumab Shows Promise in R/R Follicular Lymphoma Treatment: Phase II Results Mar 07, 2023
CLL (Chronic Lymphocytic Leukemia),Leukemia Long-Term Immune Changes in CLL with Venetoclax Plus Rituximab: MURANO Trial Mar 07, 2023
Melanoma,Skin Cancer Phase 3 Trial: Pembrolizumab as Adjuvant Therapy for Resected Melanoma Mar 07, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Sotorasib Shows Modest Clinical Activity in KRAS G12C-Mutated Colorectal Cancer Mar 07, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) ARROW Study Shows Pralsetinib Benefits Chinese Patients with Advanced NSCLC Mar 07, 2023
